SCHEMBL29520407

SCHEMBL29520407

CN1CCN2c3ccc(N)cc3OC[C@@H]2C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.43
GAA P10253 1/20 0.43
APEX1 P27695 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
KRAS P01116 2/20 0.42
SOS1 Q07889 2/20 0.42
CHRNB4 P30926 4/20 0.40
CHRNA3 P32297 4/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNA4 P43681 1/20 0.40
MAPT P10636 1/20 0.39
RAD52 P43351 1/20 0.39
WEE1 P30291 1/20 0.35
AAK1 Q2M2I8 2/20 0.35
DRD2 P14416 1/20 0.34
AXL P30530 1/20 0.34
DRD1 P21728 1/20 0.33
CHEK1 O14757 1/20 0.33
AURKA O14965 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29747448 1.00 KDM4E (0.43) KDM4EGAAAPEX1KMT2ATDP1
SCHEMBL20867739 1.00 KDM4E (0.43) KDM4EGAAAPEX1KMT2ATDP1
SCHEMBL20867673 1.00 KDM4E (0.43) KDM4EGAAAPEX1KMT2ATDP1
SCHEMBL20867867 1.00 KDM4E (0.43) KDM4EGAAAPEX1KMT2ATDP1
SCHEMBL23085953 0.89 KRAS (0.42) KDM4EGAAAPEX1KMT2ATDP1
SCHEMBL23085852 0.89 KRAS (0.42) KDM4EGAAAPEX1KMT2ATDP1
SCHEMBL21455302 0.85 KDM4E (0.39) KDM4EGAAAPEX1KMT2ATDP1
SCHEMBL23086023 0.83 SOS1 (0.37) KDM4EGAAAPEX1KMT2ATDP1
SCHEMBL20867795 0.83 GAA (0.43) KDM4EGAAAPEX1KMT2ATDP1
SCHEMBL20867873 0.83 GAA (0.43) KDM4EGAAAPEX1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022063140-A1 PYRIMIDINE AND PYRIDINE DERIVATIVES AS HPK1 MODULATOR AND METHODS USING SAME SHENZHEN IONOVA LIFE SCIENCE CO., LTD. (CN) 2022-03-31 WO disclosed